Henry Schein, Inc.
As of Oct 22, 2026, Henry Schein is in Stage 3, the topping phase, now in its first week (since Oct 16, 2026). It closed at $86.00, 5.3% below its 52-week high and above its 200-day average, which is rising.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is HSIC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
HSIC among Medical Distribution3rd of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | FOCL | Stage 4 · wk 1 | 92 | −12.4% |
| 2 | CAH | Stage 2 · wk 1 | 90 | +15.8% |
| 3 | HSIC | Stage 3 · wk 1 | 79 | +1.1% |
| 4 | MCK | Stage 2 · wk 7 | 76 | +15.0% |
| 5 | COR | Stage 2 · wk 4 | 58 | +8.4% |
| 6 | AHG | Stage 4 · wk 16 | 36 | +58.4% |
| 7 | YI | Stage 4 · wk 16 | 32 | −17.3% |
| 8 | COSM | Stage 1 · wk 7 | 13 | −37.8% |
Henry Schein: quick answers
What stage is Henry Schein in?
As of Oct 22, 2026, Henry Schein (HSIC) is in Stage 3, the topping phase. It entered Stage 3 on Oct 16, 2026 and is in its first week there. What the four stages mean
Is Henry Schein in an uptrend?
Its uptrend has stalled. Henry Schein is in Stage 3, the topping phase that follows an advance. It trades 6.4% above its 200-day average, which is rising.
How far is Henry Schein from its 52-week high?
Henry Schein closed at $86.00 on Oct 22, 2026, 5.3% below its 52-week high of $90.86. Its 52-week low is $62.32.
How has Henry Schein performed over the past year?
As of Oct 22, 2026, Henry Schein is up 33.9% over the past year and up 11.9% so far in 2026.
Which sector and industry is Henry Schein in?
Henry Schein is in the Medical Distribution industry, part of the Health Care sector.
About this companyHealth Care· Medical Distribution
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.